Nrg Oncology

This study tested whether a shorter, more intense course of radiation (given over 5 weeks) was as effective and caused fewer side effects than the standard longer course (over 7 weeks) for men who had surgery for prostate cancer. Nearly 300 men participated and were randomly assi…

This study tested whether adding a chemotherapy drug (docetaxel) to the standard post-surgery treatment of hormone therapy and radiation could better prevent prostate cancer from coming back. It involved over 600 men who had surgery for prostate cancer but were at high risk of re…

This study tested whether giving prostate cancer survivors more frequent and detailed care plans would improve their follow-up health checks. The goal was to help men who had radiation and hormone therapy get better coordinated care between their cancer doctors and primary care p…

This study tested a new way to give preventive brain radiation to people with small cell lung cancer. Researchers wanted to see if carefully avoiding a key memory area of the brain during treatment could reduce side effects like memory loss, without making the radiation less effe…

This study tested if a lower dose of radiation therapy, with or without the chemotherapy drug cisplatin, could effectively control a specific type of throat cancer linked to HPV in non-smokers. The main goal was to see if this approach could maintain high survival rates while cau…

This study tested whether adding the common diabetes medication metformin to standard chemotherapy and radiation could better control stage III non-small cell lung cancer. Researchers randomly assigned 170 patients with inoperable lung cancer to receive either the standard treatm…

This trial tested if adding a precise, high-dose radiation treatment (called SBRT) or surgery to remove tumors, on top of standard drug therapy, could better control breast cancer that had spread to only one or two other places in the body. It involved 129 patients with this 'oli…